Latorre A - Search Results

1

Machine learning survival models trained on clinical data to identify high risk patients with hormone responsive HER2 negative breast cancer.

Fanizzi A, Pomarico D, Rizzo A, Bove S, Comes MC, Didonna V, Giotta F, La Forgia D, Latorre A, Pastena MI, Petruzzellis N, Rinaldi L, Tamborra P, Zito A, Lorusso V, Massafra R. Fanizzi A, et al. Among authors: latorre a. Sci Rep. 2023 May 26;13(1):8575. doi: 10.1038/s41598-023-35344-9. Sci Rep. 2023. PMID: 37237020 Free PMC article.

2

Long-term subcutaneous recombinant interleukin-2 as maintenance therapy: biological effects and clinical implications.

Guida M, Abbate I, Casamassima A, Musci MD, Latorre A, Lorusso V, Correale M, De Lena M. Guida M, et al. Among authors: latorre a. Cancer Biother. 1995 Fall;10(3):195-203. doi: 10.1089/cbr.1995.10.195. Cancer Biother. 1995. PMID: 8547958 Clinical Trial.

3

Mitoxantrone, L-leucovorin and 5-fluorouracil: an effective and well tolerated first-line treatment for advanced breast cancer.

Lorusso V, Mancarella S, Catino A, Brandi M, Paradiso A, Latorre A, Mastria A, De Mitrio A, Guida M, De Lena M. Lorusso V, et al. Among authors: latorre a. Tumori. 1999 Jan-Feb;85(1):60-4. doi: 10.1177/030089169908500113. Tumori. 1999. PMID: 10228500

4

High efficacy of paclitaxel and doxorubicin as first-line therapy in advanced breast cancer: a phase I-II study.

De Lena M, Latorre A, Calabrese P, Catino A, Lorusso V, Mazzei A, Aloe A. De Lena M, et al. Among authors: latorre a. J Chemother. 2000 Aug;12(4):367-73. doi: 10.1179/joc.2000.12.4.367. J Chemother. 2000. PMID: 10949988 Clinical Trial.

5

Epithelial ovarian cancer: second and third line chemotherapy (review).

Latorre A, De Lena M, Catino A, Crucitta E, Sambiasi D, Guida M, Misino A, Lorusso V. Latorre A, et al. Int J Oncol. 2002 Jul;21(1):179-86. Int J Oncol. 2002. PMID: 12063566 Review.

6

Amifostine as chemoprotectant in metastatic breast cancer patients treated with doxorubicin.

Catino A, Crucitta E, Latorre A, Sambiasi D, Calabrese P, Lorusso V. Catino A, et al. Among authors: latorre a. Oncol Rep. 2003 Jan-Feb;10(1):163-7. Oncol Rep. 2003. PMID: 12469164

7

A phase I study of capecitabine in combination with vinorelbine in advanced breast cancer.

Lorusso V, Crucitta E, Silvestris N, Guida M, Misino A, Latorre A, De Lena M. Lorusso V, et al. Among authors: latorre a. Clin Breast Cancer. 2003 Jun;4(2):138-41. doi: 10.3816/cbc.2003.n.019. Clin Breast Cancer. 2003. PMID: 12864942 Clinical Trial.

8

Biomarkers predictive for clinical efficacy of taxol-based chemotherapy in advanced breast cancer.

Paradiso A, Mangia A, Chiriatti A, Tommasi S, Zito A, Latorre A, Schittulli F, Lorusso V. Paradiso A, et al. Among authors: latorre a. Ann Oncol. 2005 May;16 Suppl 4:iv14-19. doi: 10.1093/annonc/mdi902. Ann Oncol. 2005. PMID: 15923415 Free article.

9

Cytoskeleton and paclitaxel sensitivity in breast cancer: the role of beta-tubulins.

Tommasi S, Mangia A, Lacalamita R, Bellizzi A, Fedele V, Chiriatti A, Thomssen C, Kendzierski N, Latorre A, Lorusso V, Schittulli F, Zito F, Kavallaris M, Paradiso A. Tommasi S, et al. Among authors: latorre a. Int J Cancer. 2007 May 15;120(10):2078-85. doi: 10.1002/ijc.22557. Int J Cancer. 2007. PMID: 17285590 Free article.

10

Liposomal-encapsulated doxorubicin plus cyclophosphamide as first-line therapy in metastatic breast cancer: a phase II multicentric study.

Giotta F, Lorusso V, Maiello E, Filippelli G, Valerio MR, Caruso M, Verderame F, Latorre A, Colucci G. Giotta F, et al. Among authors: latorre a. Ann Oncol. 2007 Jun;18 Suppl 6:vi66-9. doi: 10.1093/annonc/mdm228. Ann Oncol. 2007. PMID: 17591836 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

518 results

Search Page